Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: J Thorac Oncol. 2019 Jun 11;14(10):1847–1852. doi: 10.1016/j.jtho.2019.05.041

Table 3.

Adverse Events Attributed to Treatment

Adverse event Grade of AE
N = 27
3 4 5
Dyspnea 1(4%)
Fatigue 1(4%)
Hyponatremia 1(4%)
Lung infection 1(4%)
Lymphocyte count decreased 1(4%)
Mucositis oral 1(4%)
Retinopathy 1(4%)
Sepsis 1(4%)
Maximum grade of any AE 6(22%) 1(4%) 0